John Rondoni compensation by year
Inspire Medical Systems Summary Compensation Table · the one fiscal year held| Component | FY2022 |
|---|---|
| Salary | $352,496 |
| Bonus | $46,250 |
| Stock awards | $374,969 |
| Option awards | $1,147,604 |
| Non-equity incentive | $177,970 |
| Pension and deferred compensation | $0 |
| All other | $8,762 |
| Total | $2,108,052 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Inspire Medical Systems, Inc. DEF 14A filed March 17, 2023, accession 0001140361-23-012285, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Inspire Medical Systems, Inc. filed document, accession 0001140361-23-012285. Every figure is read from that document and cited to the page and table it appears in. Filed March 17, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 1,648 | $415,098 | — |
| Option | 3,750 | — | $71.00 |
| Option | 4,300 | — | $194.82 |
| Option | 6,756 | — | $194.30 |
| Option | 3,173 | — | $227.53 |
| Option | 7,529 | — | $176.83 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Inspire Medical Systems, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
40 Form 4 lines since the FY2022 proxy (filed March 17, 2023)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-15 | Sale | — | 2,641 | $43.28 | 27,165 |
| 2026-05-14 | Sale | — | 700 | $43.01 | 29,806 |
| 2026-02-20 | Grant or award | — | 2,400 | $0.00 | 15,283 |
| 2026-02-20 | Tax withholding | — | 735 | $59.53 | 14,548 |
| 2026-02-20 | Grant or award | — | 15,958 | $0.00 | 30,506 |
| 2026-02-13 | Tax withholding | — | 587 | $59.76 | 12,883 |
| 2026-02-09 | Tax withholding | — | 327 | $66.33 | 13,470 |
| 2026-01-09 | Sale | 10b5-1 | 109 | $100.00 | 13,797 |
The 8 most recent of 40 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Inspire Medical Systems’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Timothy Herbert | President and Chief Executive Officer | $5,675,394 |
| Randall Ban | Chief Commercial Officer | $2,210,653 |
| Philip Ebeling | Chief Operating Officer | $2,147,557 |
| Richard Buchholz | Chief Financial Officer | $2,134,630 |
| John Rondoni · this page | Chief Technology Officer | $2,108,052 |
The full Inspire Medical Systems compensation record
free company briefThis page is one person within Inspire Medical Systems's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Inspire Medical Systems proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Inspire Medical Systems's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.